A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1421-9794|58|1|1-7

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.1, 2012-02, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of Epirubicin, Oxaliplatin, and Capecitabine (EOX) as First-Line Chemotherapy in Advanced Gastric Cancer: A Chinese Single-Center Experience

By  

Chemotherapy, Vol. 56, Iss. 3, 2010-04 ,pp. : 171-177

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study

By  

Chemotherapy, Vol. 58, Iss. 3, 2012-07 ,pp. : 225-232

Karger

Access to resources Recommend Favorite

A Pilot Study of Oxaliplatin, Fluorouracil and Folinic Acid (FOLFOX-6) as First-Line Chemotherapy in Advanced or Recurrent Gastric Cancer

By  

Chemotherapy, Vol. 54, Iss. 3, 2008-06 ,pp. : 228-235

Karger

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 232-238

Karger

Access to resources Recommend Favorite